Dietary Phytosterols and Human Aortic Valve

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by Helsinki University.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
University of Eastern Finland
Information provided by:
Helsinki University
ClinicalTrials.gov Identifier:
NCT00738933
First received: August 20, 2008
Last updated: February 11, 2011
Last verified: February 2011

August 20, 2008
February 11, 2011
April 2008
December 2011   (final data collection date for primary outcome measure)
Composition of serum and aortic valve sterols at the time of aortic valve operation [ Time Frame: Up to 4 weeks ] [ Designated as safety issue: Yes ]
Composition of serum and aortic valve sterols at the operation [ Time Frame: At the operation ] [ Designated as safety issue: Yes ]
Complete list of historical versions of study NCT00738933 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Dietary Phytosterols and Human Aortic Valve
Effects of Dietary Plant Sterols and Stanols on Sterol Composition and Structure of the Human Aortic Valve

This randomized controlled double-blind intervention study unravels influence of dietary plant sterols and stanols on the structure and the sterol composition of the human aortic valve. The study patients will include 50-60 voluntary patients from the Helsinki Univ. Central Hospital, who will undergo aortic valve surgery. The patients will be randomized into plant sterol (E), plant stanol (A) and control (C) groups. Patients in the E and A groups will be asked to consume daily 2 grams plant sterols or plant stanols, respectively, in a margarine product.

High level of serum cholesterol is a risk factor for atherosclerotic complications, including atherosclerotic aortic valve disease. Over 50 years dietary plant sterols have been used to inhibit intestinal cholesterol absorption and to decrease its levels in serum. Daily human diet contains numerous different plant sterols, of which sitosterol and campesterol are the most abundant ones. Few epidemiologic studies suggest that sitosterol and campesterol may also be involved in formation of atherosclerotic changes in human arteries. The saturated forms of sitosterol and campesterol, i.e., the plant stanols (mainly sitostanol and campestanol) are beneficial with this respect. As part of daily diet, the plant stanols decrease absorption of both cholesterol and plant sterols, and thus, are putatively even more effective in prevention of atherosclerosis than the respective plant sterols.

Our double-blind controlled intervention study unravels influence of dietary plant sterols and stanols on the structure and the sterol composition of the human aortic valve.

50-60 patients, who will undergo aortic valve surgery, will be asked to volunteer our study. The patients will be randomized into three groups: (A) a group consuming margarine containing daily 2 grams plant stanols, (E) a group consuming margarine containing daily 2 grams of plant sterols, (C) a control group consuming margarine without any plant sterols or stanols. The dietary intervention will last for 4 to 8 weeks from the randomization to the operation.

Serum samples for analyses of serum lipids, lipoproteins and sterols will be collected at the randomization and at the operation. The atherosclerotic aortic valve will be examined with respect to its composition of cholesterol, other sterols and stanols.

The aim of our study is to elucidate the effects of dietary consumption of plant sterols and stanols on the sterol composition and structure of the atherosclerotic disease-affected aortic valve in human patients.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Factorial Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
  • Hypercholesterolemia
  • Atherosclerosis
  • Dietary Supplement: Dietary plant stanols
    Daily 2 grams of plant stanols in a margarine preparation for 4-8 weeks before the operation
  • Dietary Supplement: Dietary plant sterols
    Daily 2 grams of plant sterols in a margarine preparation for 4-8 weeks before the operation
  • Dietary Supplement: placebo
    Margarine product without plant stanol or sterol esters
  • Active Comparator: A
    A group of patients consuming 2 grams plant stanols 4-8 weeks before the operation
    Intervention: Dietary Supplement: Dietary plant stanols
  • Active Comparator: E
    A group of patients consuming daily 2 grams plant sterols 4-8 weeks before the operation.
    Intervention: Dietary Supplement: Dietary plant sterols
  • Placebo Comparator: C
    Intervention: Dietary Supplement: placebo
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
60
December 2011
December 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Atherosclerotic aortic valve disease needing an aortic valve replacement operation

Exclusion Criteria:

  • None
Both
40 Years to 80 Years
No
Contact: Markku J. Nissinen, MD, PhD +358 9 4711 markku.nissinen@hus.fi
Finland
 
NCT00738933
231857
No
Markku Nissinen, MD PhD, Helsinki University Central Hospital
Helsinki University
University of Eastern Finland
Principal Investigator: Tatu A. Miettinen, professor Dept. of Medicine, Div. of Internal Medicine, Helsinki Univ. Central Hospital, Biomedicum Helsinki
Principal Investigator: Helena Gylling, Professor Department of Clinical Nutrition, University of Kuopio and Kuopion University Central Hospital, Kuopio, Finland
Principal Investigator: Markku J Nissinen, MD, PhD Dept. of Medicine, Div. of Gastroenterology, HUCH, Helsinki, Finland
Helsinki University
February 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP